We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

1 hedge funds and large institutions have $308K invested in Poseida Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 115 → 1 (-114)

100% less capital invested

Capital invested by funds: $519M → $308K (-$519M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 113

Holders
1
Holders Change
-114
Holders Change %
-99.13%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
113
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$96.1M
2
PCM
Pentwater Capital Management
Florida
-$82.8M
3
BlackRock
BlackRock
New York
-$54.1M
4
Nomura Holdings
Nomura Holdings
Japan
-$49.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$36.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
1
DekaBank Deutsche Girozentrale
Germany
$308K – – –
IA
2
IFP Advisors
Florida
$2 – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
– -$96.1M -10,011,617 Closed
PCM
4
Pentwater Capital Management
Florida
– -$82.8M -8,625,000 Closed
BlackRock
5
BlackRock
New York
– -$54.1M -5,631,488 Closed
Nomura Holdings
6
Nomura Holdings
Japan
– -$49.1M -5,115,015 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$36.8M -3,834,519 Closed
AAM
8
Alpine Associates Management
Florida
– -$19.4M -2,016,700 Closed
BCM
9
Boxer Capital Management
California
– -$19.2M -2,000,000 Closed
Geode Capital Management
10
Geode Capital Management
Massachusetts
– -$15.6M -1,629,759 Closed
State Street
11
State Street
Massachusetts
– -$15.3M -1,594,542 Closed
ACM
12
Aisling Capital Management
New York
– -$10M -1,043,267 Closed
SCM
13
Silverarc Capital Management
Massachusetts
– -$9.72M -1,012,307 Closed
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
– -$8.96M -933,102 Closed
TAL
15
TIG Advisors LLC
New York
– -$6.58M -685,595 Closed
Charles Schwab
16
Charles Schwab
California
– -$5.65M -589,007 Closed
Northern Trust
17
Northern Trust
Illinois
– -$5.48M -571,093 Closed
GCL
18
Glazer Capital LLC
New York
– -$5M -521,113 Closed
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
– -$4.45M -463,683 Closed
HCM
20
Highbridge Capital Management
New York
– -$3.84M -400,000 Closed
TC
21
Trium Capital
United Kingdom
– -$3.71M -386,407 Closed
6CM
22
683 Capital Management
New York
– -$3.36M -350,000 Closed
Wellington Management Group
23
Wellington Management Group
Massachusetts
– -$3.26M -339,715 Closed
Goldman Sachs
24
Goldman Sachs
New York
– -$3.09M -322,060 Closed
N
25
Nuveen
North Carolina
– -$2.87M -299,297 Closed
1
2 3 4 5

PSTX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2025, worth a combined $308K — down 100% from $519M a quarter earlier.

Sellers outnumbered buyers: 113 funds closed out of PSTX and 0 opened new positions — a net loss of 113 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $96.1M sold.

  • 1 institutional investor held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2025, down from 115 in Q4 2024.
  • Funds reported $308K of Poseida Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2025 and 113 closed out, a net change of -113 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2025 was Fidelity Investments, an estimated $96.1M sold.

Based on aggregated 13F filings for Q1 2025.